Treatment-resistant depression and risk of suicide

Suicide and Life-Threatening Behavior

Volumn 43, Issue 4, 2013, Pages 356-365

  Pfeiffer, Paul N ^a   Kim, Hyungjin M ^a   Ganoczy, Dara ^a   Zivin, Kara ^a   Valenstein, Marcia ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK; RISK ASSESSMENT; STATISTICS; SUICIDE; SUICIDE ATTEMPT; TREATMENT RESISTANT DEPRESSION; VETERAN; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; RISK ASSESSMENT; SUICIDE; SUICIDE, ATTEMPTED; VETERANS;

EID: 84886431087     PISSN: 03630234     EISSN: 1943278X     Source Type: Journal    
DOI: 10.1111/sltb.12022     Document Type: Article

References (37)

1. Angst, F., Stassen, H. H., Clayton, P. J., &, Angst, J., (2002). Mortality of patients with mood disorders: Follow-up over 34-38 years. Journal of Affective Disorders, 68, 167-181.
2. Arsenault-Lapierre, G., Kim, C., &, Turecki, G., (2004). Psychiatric diagnoses in 3275 suicides: A meta-analysis. BMC Psychiatry, 4, 37.
3. Berman, R. M., Narasimhan, M., &, Charney, D. S., (1997). Teatment-refractory depression: Definitions and characteristics. Depression and Anxiety, 5, 154-164.
4. Bertilsson, L., (2007). Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: Clinical and interethnic aspects. Clinical Pharmacology and Therapeutics, 82, 606-609.
5. Blow, F. C., Owen, R. E., &, Valenstein, M., (2003). Specialty care for veterans with depression in the VHA: 2002 National Depression Registry report. Ann Arbor, MI: Department of Veterans Affairs National Serious Mental Illness Treatment Research & Evaluation Center.
6. Bostwick, J. M., &, Pankratz, V. S., (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157, 1925-1932.
7. Charlson, M. E., Pompei, P., Ales, K. L., &, MacKenzie, C. R., (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Disease, 40, 373-383.
8. Cowper, D. C., Kubal, J. D., Maynard, C., &, Hynes, D. M., (2002). A primer and comparative review of major US mortality databases. Annals of Epidemiology, 1, 462-468
9. Desai, R. A., Dausey, D. J., &, Rosenheck, R. A., (2005). Mental health service delivery and suicide risk: The role of individual patient and facility factors. American Journal of Psychiatry, 162, 311-318.
10. Fava, M., (2003). Diagnosis and definition of treatment-resistant depression. Biological Psychiatry, 53, 649-659.
11. Fava, M., &, Davidson, K. G., (1996). Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America, 19, 179-200.
12. Fornaro, M., &, Giosue, P., (2010). Current nosology of treatment resistant depression: A controversy resistant to revision. Clinical Practice and Epidemiology in Mental Health, 6, 20-24.
13. Gibbons, R. D., Hur, K., Bhaumik, D. K., &, Mann, J. J., (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry, 163, 1898-1904.
14. Gibson, T. B., Jing, Y. H., Carls, G. S., Kim, E., Bagalman, J. E., Burton, W. N., et al. (2010). Cost burden of treatment resistance in patients with depression. The American Journal of Managed Care, 16, 370-377.
15. Greden, J. F., Riba, M. B., &, McInnis, M. G., (Eds.). (2011). Treatment resistant depression: A roadmap for effective care. Washington, DC: American Psychiatric Publishing.
16. Hammad, T. A., Laughren, T., &, Racoosin, J., (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339.
17. Ilgen, M. A., Bohnert, A. S. B., Ignacio, R. V., McCarthy, J. F., Valenstein, M. M., Kim, H. M., et al. (2010). Psychiatric diagnoses and risk of suicide in veterans. Archives of General Psychiatry, 67, 1152-1158.
18. Judd, L. L., Paulus, M. J., Schettler, P. J., Akiskal, H. S., Endicott, J., Leon, A. C., et al. (2000). Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? American Journal of Psychiatry, 157, 1501-1504.
19. Khan, A., Khan, S., Kolts, R., &, Brown, W. A., (2003). Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. American Journal of Psychiatry, 160, 790-792.
20. Liu, C. F., Bolkan, C., Chan, D., Yano, E. M., Rubenstein, L. V., &, Chaney, E. F., (2009). Dual use of VA and non-VA services among primary care patients with depression. Journal of General Internal Medicine, 24, 305-311.
21. Malhi, G. S., Parker, G. B., Crawford, J., Wilhelm, K., &, Mitchell, P. B., (2005). Treatment-resistant depression: Resistant to definition? Acta Psychiatrica Scandanavica, 112, 302-309.
22. McMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., et al. (2006). Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. American Journal of Human Genetics, 78, 804-814.
23. Mohr, D. C., Carmody, T., Erickson, L., Jin, L., &, Leader, J., (2011). Telephone-administered cognitive behavioral therapy for veterans served by community-based outpatient clinics. Journal of Consulting and Clinical Psychology, 79, 261-265.
24. Nelsen, M. R., &, Dunner, D. L., (1995). Clinical and differential diagnostic aspects of treatment-resistant depression. Journal of Psychiatric Research, 29, 43-50.
25. Nierenberg, A. A., (2003). Predictors of response to antidepressants: General principles and clinical implications. Psychiatric Clinics of North America, 26, 345-352.
26. Oquendo, M. A., Currier, D., &, Mann, J. J., (2006). Prospective studies of suicidal behavior in major depressive and bipolar disorders: What is the evidence for predictive risk factors? Acta Psychiatrica Scandanavica, 114, 151-158.
27. Petersen, T., Papakostas, G. I., Posternak, M. A., Kant, A., Guyker, W. M., Iosifescu, D. V., et al. (2005). Empirical testing of two models for staging antidepressant treatment resistance. Journal of Clinical Psychopharmacology, 25, 336-341.
28. Pfeiffer, P. N., Ganoczy, D., Ilgen, M., Zivin, K., &, Valenstein, M., (2009). Comorbid anxiety as a suicide risk factor among depressed veterans. Depression and Anxiety, 26, 752-757.
29. Quan, H. D., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., et al. (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care, 43, 1130-1139.
30. Ruhe, H. G., van Rooijen, G., Spijker, J., Peeters, F., &, Schene, A. H., (2012). Staging methods for treatment resistant depression: A systematic review. Journal of Affective Disorders, 137, 35-45.
31. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163, 1905-1917.
32. Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Bemyttenaere, K., et al. (2007). Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. Journal of Clinical Psychiatry, 68, 1062-1070.
33. Valenstein, M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., et al. (2002). Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40, 630-639.
34. Valenstein, M., Kim, H. M., Ganoczy, D., McCarthy, J. F., Zeber, K., Austin, K. L., et al. (2009). Higher-risk periods for suicide among VA patients receiving depression treatment: Prioritizing suicide prevention efforts. Journal of Affective Disorders, 112, 50-58.
35. Van, H. L., Schoevers, R. A., &, Dekker, J., (2008). Predicting the outcome of antidepressants and psychotherapy for depression: A qualitative, systematic review. Harvard Review of Psychiatry, 16, 225-234.
36. World Health Organization. (2004). International statistical classification of diseases and related health problems, 10th rev. (2d ed.). Geneva, Switzerland: Author.
37. Zivin, K., Kim, M., McCarthy, J. F., Austin, K. L., Hoggatt, K. J., Walters, H., et al. (2007). Suicide mortality among individuals receiving treatment for depression in the veterans affairs health system: Associations with patient and treatment setting characteristics. American Journal of Public Health, 97, 2193-2198.